Two Sigma Investments
ABEO icon

Two Sigma Investments’s Abeona Therapeutics ABEO Stock Holding History

Two Sigma Investments’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-56,948
Closed -$285K – 2989
2023
Q4 		$285K Buy
+56,948
New +$251K ﹤0.01% 2712
2020
Q3 		– Sell
-3,506
Closed -$255K – 3017
2020
Q2 		$255K Buy
3,506
+3,051
+671% +$211K ﹤0.01% 2483
2020
Q1 		$24K Buy
+455
New +$30.4K ﹤0.01% 2966
2019
Q4 		– Sell
-5,196
Closed -$294K – 3597
2019
Q3 		$294K Sell
5,196
-67
-1% -$5.02K ﹤0.01% 2978
2019
Q2 		$629K Buy
+5,263
New +$882K ﹤0.01% 2320

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WSL
Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Two Sigma Investments's ABEO Position: Q1 2024 in Review

Two Sigma Investments sold out of Abeona Therapeutics (ABEO) in Q1 2024, closing a stake of 56,948 shares — an estimated $285K sold.

Two Sigma Investments first reported a position in ABEO in Q2 2019 and held it in 5 quarters. The position peaked at $629K in Q2 2019. 56 funds tracked by Wall St. Rank hold ABEO as of Q1 2024.

  • Two Sigma Investments reported no remaining Abeona Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 56,948 Abeona Therapeutics shares in Q1 2024, an estimated $285K.
  • Two Sigma Investments first reported a position in Abeona Therapeutics in Q2 2019 and held it in 5 quarters.
  • Two Sigma Investments's Abeona Therapeutics position peaked at $629K in Q2 2019.
  • 56 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.